Single-cell sequencing reveals antitumor characteristics of intratumoral immune cells in old mice

Código QR

Single-cell sequencing reveals antitumor characteristics of intratumoral immune cells in old mice

Guardado en:

Detalles Bibliográficos
Autores principales:	Lei Lei, Lin Shi, Lianjun Zhang, Xiaobo Zhou, Xiaofeng Yang, Yanhong Su, Cangang Zhang, Kaili Ma, Huiqiang Zheng, Anjun Jiao, Haiyan Liu, Yujing Zou, Chenming Sun, Yuzhu Hou, Zhengtao Xiao, Baojun Zhang
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/783c2845ee4449d69fa3de83aaf0ab20
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors
por: Baharak Bahmani, et al.
Publicado: (2021)

Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma
por: Yan Zhou, et al.
Publicado: (2020)

Author Correction: Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma
por: Yan Zhou, et al.
Publicado: (2021)

Intratumoral SIRPα-deficient macrophages activate tumor antigen-specific cytotoxic T cells under radiotherapy
por: Zhen Bian, et al.
Publicado: (2021)

Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
por: Julienne L. Carstens, et al.
Publicado: (2017)

Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity
por: Alberto Mantovani, et al.
Publicado: (2021)

Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy
por: Meenu Sharma, et al.
Publicado: (2020)

Improving antitumor outcomes for palliative intratumoral injection therapy through lecithin–chitosan nanoparticles loading paclitaxel–cholesterol complex
por: Chu XY, et al.
Publicado: (2019)

Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma
por: Xing Hua, et al.
Publicado: (2020)

Multi-region exome sequencing reveals the intratumoral heterogeneity of surgically resected small cell lung cancer
por: Huaqiang Zhou, et al.
Publicado: (2021)

Impaired lipid biosynthesis hinders anti-tumor efficacy of intratumoral iNKT cells
por: Sicheng Fu, et al.
Publicado: (2020)

Deciphering intratumoral heterogeneity using integrated clonal tracking and single-cell transcriptome analyses
por: Humberto Contreras-Trujillo, et al.
Publicado: (2021)

A Portrait of Intratumoral Genomic and Transcriptomic Heterogeneity at Single-Cell Level in Colorectal Cancer
por: Andrea Angius, et al.
Publicado: (2021)

Trial watch: intratumoral immunotherapy
por: Juliette Humeau, et al.
Publicado: (2021)

Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer
por: Paola Cappello, et al.
Publicado: (2021)

Bridging cell-scale simulations and radiologic images to explain short-time intratumoral oxygen fluctuations.
por: Jessica L Kingsley, et al.
Publicado: (2021)

Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain
por: Manisha Singh, et al.
Publicado: (2017)

Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer
por: Qingzhu Jia, et al.
Publicado: (2018)

Type I Interferon Promotes Antitumor T Cell Response in CRPC by Regulating MDSC
por: Lilv Fan, et al.
Publicado: (2021)

Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma
por: Giulia Agliardi, et al.
Publicado: (2021)

Small cell lung cancer transformation during antitumor therapies: A systematic review
por: Chai Xing, et al.
Publicado: (2021)

The GPR171 pathway suppresses T cell activation and limits antitumor immunity
por: Yuki Fujiwara, et al.
Publicado: (2021)

Intratumoral heterogeneity and clonal evolution in liver cancer
por: Bojan Losic, et al.
Publicado: (2020)

Clinical significance of intratumor heterogeneity for gynecological carcinoma
por: Ying-Chao Yang, et al.
Publicado: (2015)

Intratumor Heterogeneity in Hepatocellular Carcinoma: Challenges and Opportunities
por: Sharanya Maanasi Kalasekar, et al.
Publicado: (2021)

Preclinical outcomes of Intratumoral Modulation Therapy for glioblastoma
por: Andrea R. Di Sebastiano, et al.
Publicado: (2018)

Novel micelle formulation of curcumin for enhancing antitumor activity and inhibiting colorectal cancer stem cells
por: Wang K, et al.
Publicado: (2012)

Vaccination with CD47 deficient tumor cells elicits an antitumor immune response in mice
por: Yang Li, et al.
Publicado: (2020)

Induction of ROS and DNA damage-dependent senescence by icaritin contributes to its antitumor activity in hepatocellular carcinoma cells
por: Shikang Wang, et al.
Publicado: (2019)

Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients
por: Cindy Neuzillet, et al.
Publicado: (2021)

Combination of intratumoral invariant natural killer T cells and interferon-gamma is associated with prognosis of hepatocellular carcinoma after curative resection.
por: Yong-Sheng Xiao, et al.
Publicado: (2013)

Simple and effective bacterial-based intratumoral cancer immunotherapy
por: Teresa Neeman, et al.
Publicado: (2021)

Advances in Injectable In Situ-Forming Hydrogels for Intratumoral Treatment
por: Gi Ru Shin, et al.
Publicado: (2021)

Identification of immune-related subtypes of colorectal cancer to improve antitumor immunotherapy
por: Xiaobo Zheng, et al.
Publicado: (2021)

Worst Pattern of Perineural Invasion Redefines the Spatial Localization of Nerves in Oral Squamous Cell Carcinoma
por: Yong Fu, et al.
Publicado: (2021)

Fas signaling-mediated TH9 cell differentiation favors bowel inflammation and antitumor functions
por: Yingying Shen, et al.
Publicado: (2019)

Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1/PD-L1 pathway
por: Chunyi Shen, et al.
Publicado: (2021)

BDNF Acts as a Prognostic Factor Associated with Tumor-Infiltrating Th2 Cells in Pancreatic Adenocarcinoma
por: Yanan Zhu, et al.
Publicado: (2021)

Retraction Note: Tumor-specific Th2 responses inhibit growth of CT26 colon-cancer cells in mice via converting intratumor regulatory T cells to Th9 cells
por: Jiang-Qi Liu, et al.
Publicado: (2021)

Effect of intratumoral administration on biodistribution of 64Cu-labeled nanoshells
por: Xie H, et al.
Publicado: (2012)